+

AU2001268264A1 - Resazurin-based cytotoxicity assay - Google Patents

Resazurin-based cytotoxicity assay

Info

Publication number
AU2001268264A1
AU2001268264A1 AU2001268264A AU6826401A AU2001268264A1 AU 2001268264 A1 AU2001268264 A1 AU 2001268264A1 AU 2001268264 A AU2001268264 A AU 2001268264A AU 6826401 A AU6826401 A AU 6826401A AU 2001268264 A1 AU2001268264 A1 AU 2001268264A1
Authority
AU
Australia
Prior art keywords
resazurin
cytotoxicity assay
based cytotoxicity
assay
cytotoxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268264A
Inventor
Mark Johnson
Michael Mcmillian
Lekha Patel
Zhong Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU2001268264A1 publication Critical patent/AU2001268264A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2304/00Chemical means of detecting microorganisms
    • C12Q2304/20Redox indicators
    • C12Q2304/22Resazurin; Resorufin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001268264A 2000-06-20 2001-06-08 Resazurin-based cytotoxicity assay Abandoned AU2001268264A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59700700A 2000-06-20 2000-06-20
US09597007 2000-06-20
PCT/US2001/018570 WO2001098531A1 (en) 2000-06-20 2001-06-08 Resazurin-based cytotoxicity assay

Publications (1)

Publication Number Publication Date
AU2001268264A1 true AU2001268264A1 (en) 2002-01-02

Family

ID=24389664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268264A Abandoned AU2001268264A1 (en) 2000-06-20 2001-06-08 Resazurin-based cytotoxicity assay

Country Status (2)

Country Link
AU (1) AU2001268264A1 (en)
WO (1) WO2001098531A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982152B2 (en) 2002-04-17 2006-01-03 Promega Corporation Cytotoxicity assay
US7264933B2 (en) * 2003-03-26 2007-09-04 Synergy Biosystems Ltd Methods to identify biologically active agents and synergistic combinations
KR20060095993A (en) * 2003-09-29 2006-09-05 가부시키가이샤 옥시제닉스 How to assess organ function
US11597960B2 (en) 2019-07-01 2023-03-07 General Electric Company Assessment of micro-organism presence
US11590502B2 (en) 2019-07-01 2023-02-28 General Electric Company Assessment of micro-organism presence

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5501959A (en) * 1989-01-17 1996-03-26 Alamar Biosciences Laboratory, Inc. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents
JPH02211899A (en) * 1989-02-10 1990-08-23 Terumo Corp Measurement of drug sensibility of bacterium
US5756527A (en) * 1995-06-07 1998-05-26 Ontogen Corporation Imidazole derivatives useful as modulators of multi drug resistances
WO1997004008A1 (en) * 1995-07-20 1997-02-06 Xoma Corporation Anti-fungal peptides

Also Published As

Publication number Publication date
WO2001098531A1 (en) 2001-12-27

Similar Documents

Publication Publication Date Title
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2002211620A1 (en) Autoanastomosis
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001296577A1 (en) Chlorophyllases
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001281921A1 (en) Bdellosomes
AU2001232041A1 (en) Improved assay
AU2001232132A1 (en) Novel assay
AU2001246864A1 (en) Hypotensors
AU2002214354A1 (en) Neck-phone
AU2001268264A1 (en) Resazurin-based cytotoxicity assay
AU2001240793A1 (en) Novel assay
AU2001295713A1 (en) Blast-processing
AU2001284173A1 (en) Calycins
AU2001260192A1 (en) Glycinamides
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载